Kaufmann, M., Maass, N., Costa, S., Schneeweiss, A., Loibl, S., Sütterlin, M., . . . Minckwitz, G. v. (2010). First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial. European journal of cancer, 46(18), .
Chicago-Zitierstil (17. Ausg.)Kaufmann, Manfred, et al. "First-line Therapy with Moderate Dose Capecitabine in Metastatic Breast Cancer Is Safe and Active: Results of the MONICA Trial." European Journal of Cancer 46, no. 18 (2010).
MLA-Zitierstil (9. Ausg.)Kaufmann, Manfred, et al. "First-line Therapy with Moderate Dose Capecitabine in Metastatic Breast Cancer Is Safe and Active: Results of the MONICA Trial." European Journal of Cancer, vol. 46, no. 18, 2010.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.